nodes	percent_of_prediction	percent_of_DWPC	metapath
Clarithromycin—SLC22A7—Fluorouracil—urinary bladder cancer	0.152	0.237	CbGbCtD
Clarithromycin—ABCB1—Mitomycin—urinary bladder cancer	0.117	0.182	CbGbCtD
Clarithromycin—SLC22A7—Methotrexate—urinary bladder cancer	0.0839	0.131	CbGbCtD
Clarithromycin—CYP3A4—Thiotepa—urinary bladder cancer	0.0532	0.0827	CbGbCtD
Clarithromycin—CYP3A5—Etoposide—urinary bladder cancer	0.037	0.0575	CbGbCtD
Clarithromycin—ABCB1—Gemcitabine—urinary bladder cancer	0.0337	0.0524	CbGbCtD
Clarithromycin—CYP1A2—Fluorouracil—urinary bladder cancer	0.033	0.0513	CbGbCtD
Clarithromycin—CYP1A2—Etoposide—urinary bladder cancer	0.0275	0.0428	CbGbCtD
Clarithromycin—ABCB1—Cisplatin—urinary bladder cancer	0.0245	0.0381	CbGbCtD
Clarithromycin—ABCB1—Etoposide—urinary bladder cancer	0.0241	0.0374	CbGbCtD
Clarithromycin—ABCB1—Doxorubicin—urinary bladder cancer	0.0164	0.0255	CbGbCtD
Clarithromycin—ABCB1—Methotrexate—urinary bladder cancer	0.0159	0.0247	CbGbCtD
Clarithromycin—CYP3A4—Etoposide—urinary bladder cancer	0.0144	0.0224	CbGbCtD
Clarithromycin—CYP3A4—Doxorubicin—urinary bladder cancer	0.00983	0.0153	CbGbCtD
Clarithromycin—CYP2C19—urine—urinary bladder cancer	0.000609	0.202	CbGeAlD
Clarithromycin—CYP1A2—urine—urinary bladder cancer	0.000498	0.165	CbGeAlD
Clarithromycin—CYP3A4—urine—urinary bladder cancer	0.00036	0.119	CbGeAlD
Clarithromycin—SLC22A7—renal system—urinary bladder cancer	0.000308	0.102	CbGeAlD
Clarithromycin—Stevens-Johnson syndrome—Doxorubicin—urinary bladder cancer	0.000182	0.000661	CcSEcCtD
Clarithromycin—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000181	0.000659	CcSEcCtD
Clarithromycin—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000181	0.000657	CcSEcCtD
Clarithromycin—Renal failure—Doxorubicin—urinary bladder cancer	0.00018	0.000656	CcSEcCtD
Clarithromycin—Erythema multiforme—Methotrexate—urinary bladder cancer	0.00018	0.000654	CcSEcCtD
Clarithromycin—Urticaria—Etoposide—urinary bladder cancer	0.000179	0.000651	CcSEcCtD
Clarithromycin—Haemoglobin—Epirubicin—urinary bladder cancer	0.000179	0.00065	CcSEcCtD
Clarithromycin—Stomatitis—Doxorubicin—urinary bladder cancer	0.000179	0.00065	CcSEcCtD
Clarithromycin—Jaundice—Doxorubicin—urinary bladder cancer	0.000179	0.00065	CcSEcCtD
Clarithromycin—Rhinitis—Epirubicin—urinary bladder cancer	0.000178	0.000649	CcSEcCtD
Clarithromycin—Abdominal pain—Etoposide—urinary bladder cancer	0.000178	0.000648	CcSEcCtD
Clarithromycin—Body temperature increased—Etoposide—urinary bladder cancer	0.000178	0.000648	CcSEcCtD
Clarithromycin—Conjunctivitis—Doxorubicin—urinary bladder cancer	0.000178	0.000648	CcSEcCtD
Clarithromycin—Haemorrhage—Epirubicin—urinary bladder cancer	0.000178	0.000647	CcSEcCtD
Clarithromycin—Hepatitis—Epirubicin—urinary bladder cancer	0.000178	0.000647	CcSEcCtD
Clarithromycin—Eye disorder—Methotrexate—urinary bladder cancer	0.000178	0.000646	CcSEcCtD
Clarithromycin—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000178	0.000646	CcSEcCtD
Clarithromycin—Tinnitus—Methotrexate—urinary bladder cancer	0.000177	0.000645	CcSEcCtD
Clarithromycin—Asthenia—Cisplatin—urinary bladder cancer	0.000177	0.000642	CcSEcCtD
Clarithromycin—Pharyngitis—Epirubicin—urinary bladder cancer	0.000177	0.000642	CcSEcCtD
Clarithromycin—Cardiac disorder—Methotrexate—urinary bladder cancer	0.000177	0.000642	CcSEcCtD
Clarithromycin—Urinary tract disorder—Epirubicin—urinary bladder cancer	0.000176	0.000639	CcSEcCtD
Clarithromycin—Haematuria—Doxorubicin—urinary bladder cancer	0.000175	0.000636	CcSEcCtD
Clarithromycin—Connective tissue disorder—Epirubicin—urinary bladder cancer	0.000175	0.000636	CcSEcCtD
Clarithromycin—Urethral disorder—Epirubicin—urinary bladder cancer	0.000175	0.000634	CcSEcCtD
Clarithromycin—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	0.000174	0.000631	CcSEcCtD
Clarithromycin—Epistaxis—Doxorubicin—urinary bladder cancer	0.000173	0.000629	CcSEcCtD
Clarithromycin—Angiopathy—Methotrexate—urinary bladder cancer	0.000173	0.000627	CcSEcCtD
Clarithromycin—CYP3A5—prostate gland—urinary bladder cancer	0.000172	0.057	CbGeAlD
Clarithromycin—Immune system disorder—Methotrexate—urinary bladder cancer	0.000172	0.000624	CcSEcCtD
Clarithromycin—Dizziness—Fluorouracil—urinary bladder cancer	0.000172	0.000624	CcSEcCtD
Clarithromycin—Visual impairment—Epirubicin—urinary bladder cancer	0.000172	0.000623	CcSEcCtD
Clarithromycin—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.000171	0.000623	CcSEcCtD
Clarithromycin—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.000171	0.000622	CcSEcCtD
Clarithromycin—Chills—Methotrexate—urinary bladder cancer	0.000171	0.00062	CcSEcCtD
Clarithromycin—Diarrhoea—Cisplatin—urinary bladder cancer	0.000169	0.000612	CcSEcCtD
Clarithromycin—Erythema multiforme—Epirubicin—urinary bladder cancer	0.000168	0.000612	CcSEcCtD
Clarithromycin—Vomiting—Gemcitabine—urinary bladder cancer	0.000168	0.000611	CcSEcCtD
Clarithromycin—Mental disorder—Methotrexate—urinary bladder cancer	0.000167	0.000606	CcSEcCtD
Clarithromycin—Rash—Gemcitabine—urinary bladder cancer	0.000167	0.000605	CcSEcCtD
Clarithromycin—Dermatitis—Gemcitabine—urinary bladder cancer	0.000166	0.000605	CcSEcCtD
Clarithromycin—Eye disorder—Epirubicin—urinary bladder cancer	0.000166	0.000605	CcSEcCtD
Clarithromycin—Hypersensitivity—Etoposide—urinary bladder cancer	0.000166	0.000604	CcSEcCtD
Clarithromycin—Tinnitus—Epirubicin—urinary bladder cancer	0.000166	0.000603	CcSEcCtD
Clarithromycin—Malnutrition—Methotrexate—urinary bladder cancer	0.000166	0.000602	CcSEcCtD
Clarithromycin—Haemoglobin—Doxorubicin—urinary bladder cancer	0.000166	0.000602	CcSEcCtD
Clarithromycin—Headache—Gemcitabine—urinary bladder cancer	0.000166	0.000602	CcSEcCtD
Clarithromycin—Cardiac disorder—Epirubicin—urinary bladder cancer	0.000165	0.0006	CcSEcCtD
Clarithromycin—Flushing—Epirubicin—urinary bladder cancer	0.000165	0.0006	CcSEcCtD
Clarithromycin—Vomiting—Fluorouracil—urinary bladder cancer	0.000165	0.0006	CcSEcCtD
Clarithromycin—Rhinitis—Doxorubicin—urinary bladder cancer	0.000165	0.0006	CcSEcCtD
Clarithromycin—Haemorrhage—Doxorubicin—urinary bladder cancer	0.000165	0.000599	CcSEcCtD
Clarithromycin—Hepatitis—Doxorubicin—urinary bladder cancer	0.000165	0.000599	CcSEcCtD
Clarithromycin—Rash—Fluorouracil—urinary bladder cancer	0.000164	0.000595	CcSEcCtD
Clarithromycin—Dermatitis—Fluorouracil—urinary bladder cancer	0.000164	0.000595	CcSEcCtD
Clarithromycin—Pharyngitis—Doxorubicin—urinary bladder cancer	0.000163	0.000594	CcSEcCtD
Clarithromycin—Headache—Fluorouracil—urinary bladder cancer	0.000163	0.000591	CcSEcCtD
Clarithromycin—Urinary tract disorder—Doxorubicin—urinary bladder cancer	0.000163	0.000591	CcSEcCtD
Clarithromycin—Dysgeusia—Methotrexate—urinary bladder cancer	0.000162	0.000589	CcSEcCtD
Clarithromycin—Asthenia—Etoposide—urinary bladder cancer	0.000162	0.000588	CcSEcCtD
Clarithromycin—Connective tissue disorder—Doxorubicin—urinary bladder cancer	0.000162	0.000588	CcSEcCtD
Clarithromycin—Angiopathy—Epirubicin—urinary bladder cancer	0.000162	0.000587	CcSEcCtD
Clarithromycin—Urethral disorder—Doxorubicin—urinary bladder cancer	0.000161	0.000587	CcSEcCtD
Clarithromycin—Immune system disorder—Epirubicin—urinary bladder cancer	0.000161	0.000584	CcSEcCtD
Clarithromycin—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.00016	0.000583	CcSEcCtD
Clarithromycin—Back pain—Methotrexate—urinary bladder cancer	0.00016	0.000582	CcSEcCtD
Clarithromycin—Chills—Epirubicin—urinary bladder cancer	0.00016	0.000581	CcSEcCtD
Clarithromycin—Pruritus—Etoposide—urinary bladder cancer	0.00016	0.00058	CcSEcCtD
Clarithromycin—Visual impairment—Doxorubicin—urinary bladder cancer	0.000159	0.000577	CcSEcCtD
Clarithromycin—Nausea—Gemcitabine—urinary bladder cancer	0.000157	0.00057	CcSEcCtD
Clarithromycin—Vomiting—Cisplatin—urinary bladder cancer	0.000157	0.000569	CcSEcCtD
Clarithromycin—Mental disorder—Epirubicin—urinary bladder cancer	0.000156	0.000567	CcSEcCtD
Clarithromycin—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.000156	0.000566	CcSEcCtD
Clarithromycin—Rash—Cisplatin—urinary bladder cancer	0.000155	0.000564	CcSEcCtD
Clarithromycin—Dermatitis—Cisplatin—urinary bladder cancer	0.000155	0.000564	CcSEcCtD
Clarithromycin—Malnutrition—Epirubicin—urinary bladder cancer	0.000155	0.000563	CcSEcCtD
Clarithromycin—Diarrhoea—Etoposide—urinary bladder cancer	0.000154	0.000561	CcSEcCtD
Clarithromycin—Nausea—Fluorouracil—urinary bladder cancer	0.000154	0.000561	CcSEcCtD
Clarithromycin—Eye disorder—Doxorubicin—urinary bladder cancer	0.000154	0.000559	CcSEcCtD
Clarithromycin—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000154	0.000558	CcSEcCtD
Clarithromycin—Tinnitus—Doxorubicin—urinary bladder cancer	0.000154	0.000558	CcSEcCtD
Clarithromycin—Anaemia—Methotrexate—urinary bladder cancer	0.000153	0.000556	CcSEcCtD
Clarithromycin—Flushing—Doxorubicin—urinary bladder cancer	0.000153	0.000556	CcSEcCtD
Clarithromycin—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.000153	0.000556	CcSEcCtD
Clarithromycin—Flatulence—Epirubicin—urinary bladder cancer	0.000153	0.000555	CcSEcCtD
Clarithromycin—Tension—Epirubicin—urinary bladder cancer	0.000152	0.000553	CcSEcCtD
Clarithromycin—Dysgeusia—Epirubicin—urinary bladder cancer	0.000152	0.000552	CcSEcCtD
Clarithromycin—Nervousness—Epirubicin—urinary bladder cancer	0.000151	0.000547	CcSEcCtD
Clarithromycin—Back pain—Epirubicin—urinary bladder cancer	0.00015	0.000545	CcSEcCtD
Clarithromycin—Angiopathy—Doxorubicin—urinary bladder cancer	0.000149	0.000543	CcSEcCtD
Clarithromycin—Malaise—Methotrexate—urinary bladder cancer	0.000149	0.000543	CcSEcCtD
Clarithromycin—Dizziness—Etoposide—urinary bladder cancer	0.000149	0.000542	CcSEcCtD
Clarithromycin—Muscle spasms—Epirubicin—urinary bladder cancer	0.000149	0.000541	CcSEcCtD
Clarithromycin—Immune system disorder—Doxorubicin—urinary bladder cancer	0.000149	0.000541	CcSEcCtD
Clarithromycin—Vertigo—Methotrexate—urinary bladder cancer	0.000149	0.000541	CcSEcCtD
Clarithromycin—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.000148	0.00054	CcSEcCtD
Clarithromycin—Leukopenia—Methotrexate—urinary bladder cancer	0.000148	0.000539	CcSEcCtD
Clarithromycin—Chills—Doxorubicin—urinary bladder cancer	0.000148	0.000537	CcSEcCtD
Clarithromycin—Nausea—Cisplatin—urinary bladder cancer	0.000146	0.000532	CcSEcCtD
Clarithromycin—Cough—Methotrexate—urinary bladder cancer	0.000145	0.000525	CcSEcCtD
Clarithromycin—Mental disorder—Doxorubicin—urinary bladder cancer	0.000144	0.000524	CcSEcCtD
Clarithromycin—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000144	0.000523	CcSEcCtD
Clarithromycin—Convulsion—Methotrexate—urinary bladder cancer	0.000143	0.000521	CcSEcCtD
Clarithromycin—Vomiting—Etoposide—urinary bladder cancer	0.000143	0.000521	CcSEcCtD
Clarithromycin—Malnutrition—Doxorubicin—urinary bladder cancer	0.000143	0.000521	CcSEcCtD
Clarithromycin—Anaemia—Epirubicin—urinary bladder cancer	0.000143	0.000521	CcSEcCtD
Clarithromycin—Agitation—Epirubicin—urinary bladder cancer	0.000142	0.000518	CcSEcCtD
Clarithromycin—Rash—Etoposide—urinary bladder cancer	0.000142	0.000517	CcSEcCtD
Clarithromycin—Dermatitis—Etoposide—urinary bladder cancer	0.000142	0.000517	CcSEcCtD
Clarithromycin—Headache—Etoposide—urinary bladder cancer	0.000141	0.000514	CcSEcCtD
Clarithromycin—Flatulence—Doxorubicin—urinary bladder cancer	0.000141	0.000513	CcSEcCtD
Clarithromycin—Chest pain—Methotrexate—urinary bladder cancer	0.000141	0.000512	CcSEcCtD
Clarithromycin—Myalgia—Methotrexate—urinary bladder cancer	0.000141	0.000512	CcSEcCtD
Clarithromycin—Tension—Doxorubicin—urinary bladder cancer	0.000141	0.000511	CcSEcCtD
Clarithromycin—Dysgeusia—Doxorubicin—urinary bladder cancer	0.00014	0.00051	CcSEcCtD
Clarithromycin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.00014	0.000509	CcSEcCtD
Clarithromycin—Malaise—Epirubicin—urinary bladder cancer	0.00014	0.000508	CcSEcCtD
Clarithromycin—Discomfort—Methotrexate—urinary bladder cancer	0.000139	0.000506	CcSEcCtD
Clarithromycin—Nervousness—Doxorubicin—urinary bladder cancer	0.000139	0.000506	CcSEcCtD
Clarithromycin—Vertigo—Epirubicin—urinary bladder cancer	0.000139	0.000506	CcSEcCtD
Clarithromycin—Leukopenia—Epirubicin—urinary bladder cancer	0.000139	0.000504	CcSEcCtD
Clarithromycin—Back pain—Doxorubicin—urinary bladder cancer	0.000139	0.000504	CcSEcCtD
Clarithromycin—Muscle spasms—Doxorubicin—urinary bladder cancer	0.000138	0.000501	CcSEcCtD
Clarithromycin—Palpitations—Epirubicin—urinary bladder cancer	0.000137	0.000498	CcSEcCtD
Clarithromycin—Confusional state—Methotrexate—urinary bladder cancer	0.000136	0.000495	CcSEcCtD
Clarithromycin—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000136	0.000495	CcSEcCtD
Clarithromycin—Cough—Epirubicin—urinary bladder cancer	0.000135	0.000491	CcSEcCtD
Clarithromycin—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000135	0.000491	CcSEcCtD
Clarithromycin—Convulsion—Epirubicin—urinary bladder cancer	0.000134	0.000488	CcSEcCtD
Clarithromycin—Infection—Methotrexate—urinary bladder cancer	0.000134	0.000488	CcSEcCtD
Clarithromycin—Nausea—Etoposide—urinary bladder cancer	0.000134	0.000487	CcSEcCtD
Clarithromycin—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000133	0.000484	CcSEcCtD
Clarithromycin—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000133	0.000482	CcSEcCtD
Clarithromycin—Anaemia—Doxorubicin—urinary bladder cancer	0.000133	0.000482	CcSEcCtD
Clarithromycin—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000132	0.000481	CcSEcCtD
Clarithromycin—Chest pain—Epirubicin—urinary bladder cancer	0.000132	0.000479	CcSEcCtD
Clarithromycin—Myalgia—Epirubicin—urinary bladder cancer	0.000132	0.000479	CcSEcCtD
Clarithromycin—Agitation—Doxorubicin—urinary bladder cancer	0.000132	0.000479	CcSEcCtD
Clarithromycin—Anxiety—Epirubicin—urinary bladder cancer	0.000131	0.000478	CcSEcCtD
Clarithromycin—Skin disorder—Methotrexate—urinary bladder cancer	0.000131	0.000477	CcSEcCtD
Clarithromycin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000131	0.000476	CcSEcCtD
Clarithromycin—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000131	0.000475	CcSEcCtD
Clarithromycin—Discomfort—Epirubicin—urinary bladder cancer	0.00013	0.000474	CcSEcCtD
Clarithromycin—Malaise—Doxorubicin—urinary bladder cancer	0.000129	0.00047	CcSEcCtD
Clarithromycin—Dry mouth—Epirubicin—urinary bladder cancer	0.000129	0.000469	CcSEcCtD
Clarithromycin—Vertigo—Doxorubicin—urinary bladder cancer	0.000129	0.000468	CcSEcCtD
Clarithromycin—Anorexia—Methotrexate—urinary bladder cancer	0.000129	0.000468	CcSEcCtD
Clarithromycin—Leukopenia—Doxorubicin—urinary bladder cancer	0.000128	0.000466	CcSEcCtD
Clarithromycin—Confusional state—Epirubicin—urinary bladder cancer	0.000128	0.000463	CcSEcCtD
Clarithromycin—Palpitations—Doxorubicin—urinary bladder cancer	0.000127	0.000461	CcSEcCtD
Clarithromycin—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000126	0.00046	CcSEcCtD
Clarithromycin—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000126	0.000458	CcSEcCtD
Clarithromycin—Infection—Epirubicin—urinary bladder cancer	0.000126	0.000457	CcSEcCtD
Clarithromycin—Cough—Doxorubicin—urinary bladder cancer	0.000125	0.000455	CcSEcCtD
Clarithromycin—Convulsion—Doxorubicin—urinary bladder cancer	0.000124	0.000452	CcSEcCtD
Clarithromycin—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000124	0.000451	CcSEcCtD
Clarithromycin—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000124	0.00045	CcSEcCtD
Clarithromycin—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000123	0.000447	CcSEcCtD
Clarithromycin—Skin disorder—Epirubicin—urinary bladder cancer	0.000123	0.000446	CcSEcCtD
Clarithromycin—CYP1A2—Aryl Hydrocarbon Receptor—RB1—urinary bladder cancer	0.000123	0.00154	CbGpPWpGaD
Clarithromycin—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000122	0.000444	CcSEcCtD
Clarithromycin—Insomnia—Methotrexate—urinary bladder cancer	0.000122	0.000444	CcSEcCtD
Clarithromycin—Chest pain—Doxorubicin—urinary bladder cancer	0.000122	0.000444	CcSEcCtD
Clarithromycin—Myalgia—Doxorubicin—urinary bladder cancer	0.000122	0.000444	CcSEcCtD
Clarithromycin—CYP1A2—renal system—urinary bladder cancer	0.000122	0.0403	CbGeAlD
Clarithromycin—Anxiety—Doxorubicin—urinary bladder cancer	0.000122	0.000442	CcSEcCtD
Clarithromycin—Paraesthesia—Methotrexate—urinary bladder cancer	0.000121	0.000441	CcSEcCtD
Clarithromycin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000121	0.000441	CcSEcCtD
Clarithromycin—CYP2C19—Arachidonic acid metabolism—PTGS2—urinary bladder cancer	0.000121	0.00152	CbGpPWpGaD
Clarithromycin—Discomfort—Doxorubicin—urinary bladder cancer	0.000121	0.000438	CcSEcCtD
Clarithromycin—Anorexia—Epirubicin—urinary bladder cancer	0.000121	0.000438	CcSEcCtD
Clarithromycin—Dyspnoea—Methotrexate—urinary bladder cancer	0.00012	0.000438	CcSEcCtD
Clarithromycin—Somnolence—Methotrexate—urinary bladder cancer	0.00012	0.000437	CcSEcCtD
Clarithromycin—Dry mouth—Doxorubicin—urinary bladder cancer	0.000119	0.000434	CcSEcCtD
Clarithromycin—Dyspepsia—Methotrexate—urinary bladder cancer	0.000119	0.000432	CcSEcCtD
Clarithromycin—Confusional state—Doxorubicin—urinary bladder cancer	0.000118	0.000429	CcSEcCtD
Clarithromycin—Decreased appetite—Methotrexate—urinary bladder cancer	0.000117	0.000427	CcSEcCtD
Clarithromycin—CYP3A5—renal system—urinary bladder cancer	0.000117	0.0389	CbGeAlD
Clarithromycin—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000117	0.000425	CcSEcCtD
Clarithromycin—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000117	0.000424	CcSEcCtD
Clarithromycin—Fatigue—Methotrexate—urinary bladder cancer	0.000117	0.000423	CcSEcCtD
Clarithromycin—Infection—Doxorubicin—urinary bladder cancer	0.000116	0.000423	CcSEcCtD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—urinary bladder cancer	0.000116	0.00146	CbGpPWpGaD
Clarithromycin—CYP1A2—Phase II conjugation—GSTP1—urinary bladder cancer	0.000116	0.00146	CbGpPWpGaD
Clarithromycin—Pain—Methotrexate—urinary bladder cancer	0.000116	0.00042	CcSEcCtD
Clarithromycin—ABCB1—HIF-1-alpha transcription factor network—CREBBP—urinary bladder cancer	0.000115	0.00145	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—urinary bladder cancer	0.000115	0.00145	CbGpPWpGaD
Clarithromycin—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000115	0.000419	CcSEcCtD
Clarithromycin—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000115	0.000417	CcSEcCtD
Clarithromycin—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000115	0.000416	CcSEcCtD
Clarithromycin—Insomnia—Epirubicin—urinary bladder cancer	0.000114	0.000416	CcSEcCtD
Clarithromycin—Skin disorder—Doxorubicin—urinary bladder cancer	0.000114	0.000413	CcSEcCtD
Clarithromycin—Paraesthesia—Epirubicin—urinary bladder cancer	0.000114	0.000413	CcSEcCtD
Clarithromycin—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000113	0.000411	CcSEcCtD
Clarithromycin—Dyspnoea—Epirubicin—urinary bladder cancer	0.000113	0.00041	CcSEcCtD
Clarithromycin—Somnolence—Epirubicin—urinary bladder cancer	0.000112	0.000409	CcSEcCtD
Clarithromycin—CYP3A5—Biological oxidations—GSTP1—urinary bladder cancer	0.000112	0.00142	CbGpPWpGaD
Clarithromycin—Anorexia—Doxorubicin—urinary bladder cancer	0.000112	0.000405	CcSEcCtD
Clarithromycin—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000111	0.000405	CcSEcCtD
Clarithromycin—Dyspepsia—Epirubicin—urinary bladder cancer	0.000111	0.000405	CcSEcCtD
Clarithromycin—CYP3A5—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000111	0.0014	CbGpPWpGaD
Clarithromycin—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000111	0.000402	CcSEcCtD
Clarithromycin—Decreased appetite—Epirubicin—urinary bladder cancer	0.00011	0.0004	CcSEcCtD
Clarithromycin—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000109	0.000397	CcSEcCtD
Clarithromycin—Fatigue—Epirubicin—urinary bladder cancer	0.000109	0.000396	CcSEcCtD
Clarithromycin—Pain—Epirubicin—urinary bladder cancer	0.000108	0.000393	CcSEcCtD
Clarithromycin—Constipation—Epirubicin—urinary bladder cancer	0.000108	0.000393	CcSEcCtD
Clarithromycin—CYP2C19—vagina—urinary bladder cancer	0.000108	0.0357	CbGeAlD
Clarithromycin—Urticaria—Methotrexate—urinary bladder cancer	0.000107	0.00039	CcSEcCtD
Clarithromycin—Abdominal pain—Methotrexate—urinary bladder cancer	0.000107	0.000388	CcSEcCtD
Clarithromycin—Body temperature increased—Methotrexate—urinary bladder cancer	0.000107	0.000388	CcSEcCtD
Clarithromycin—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000107	0.000387	CcSEcCtD
Clarithromycin—CYP1A2—Phase II conjugation—GSTM1—urinary bladder cancer	0.000106	0.00134	CbGpPWpGaD
Clarithromycin—Insomnia—Doxorubicin—urinary bladder cancer	0.000106	0.000385	CcSEcCtD
Clarithromycin—ABCB1—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000105	0.00132	CbGpPWpGaD
Clarithromycin—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000105	0.000382	CcSEcCtD
Clarithromycin—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000104	0.000379	CcSEcCtD
Clarithromycin—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000104	0.000379	CcSEcCtD
Clarithromycin—Somnolence—Doxorubicin—urinary bladder cancer	0.000104	0.000378	CcSEcCtD
Clarithromycin—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000103	0.000376	CcSEcCtD
Clarithromycin—CYP3A5—Biological oxidations—GSTM1—urinary bladder cancer	0.000103	0.0013	CbGpPWpGaD
Clarithromycin—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000103	0.000374	CcSEcCtD
Clarithromycin—CYP3A5—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000102	0.00128	CbGpPWpGaD
Clarithromycin—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000102	0.00037	CcSEcCtD
Clarithromycin—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000101	0.000367	CcSEcCtD
Clarithromycin—Fatigue—Doxorubicin—urinary bladder cancer	0.000101	0.000367	CcSEcCtD
Clarithromycin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—urinary bladder cancer	0.000101	0.00127	CbGpPWpGaD
Clarithromycin—CYP1A2—Biological oxidations—HPGDS—urinary bladder cancer	0.000101	0.00127	CbGpPWpGaD
Clarithromycin—Urticaria—Epirubicin—urinary bladder cancer	0.0001	0.000365	CcSEcCtD
Clarithromycin—Constipation—Doxorubicin—urinary bladder cancer	0.0001	0.000364	CcSEcCtD
Clarithromycin—Pain—Doxorubicin—urinary bladder cancer	0.0001	0.000364	CcSEcCtD
Clarithromycin—Abdominal pain—Epirubicin—urinary bladder cancer	0.0001	0.000363	CcSEcCtD
Clarithromycin—Body temperature increased—Epirubicin—urinary bladder cancer	0.0001	0.000363	CcSEcCtD
Clarithromycin—Hypersensitivity—Methotrexate—urinary bladder cancer	9.96e-05	0.000362	CcSEcCtD
Clarithromycin—CYP1A2—Biological oxidations—GSTT1—urinary bladder cancer	9.77e-05	0.00123	CbGpPWpGaD
Clarithromycin—CYP3A4—Biological oxidations—NAT2—urinary bladder cancer	9.72e-05	0.00122	CbGpPWpGaD
Clarithromycin—Asthenia—Methotrexate—urinary bladder cancer	9.7e-05	0.000352	CcSEcCtD
Clarithromycin—Feeling abnormal—Doxorubicin—urinary bladder cancer	9.64e-05	0.00035	CcSEcCtD
Clarithromycin—CYP3A4—Metapathway biotransformation—NAT2—urinary bladder cancer	9.59e-05	0.00121	CbGpPWpGaD
Clarithromycin—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	9.57e-05	0.000348	CcSEcCtD
Clarithromycin—Pruritus—Methotrexate—urinary bladder cancer	9.56e-05	0.000347	CcSEcCtD
Clarithromycin—CYP3A7—Metabolism—GSTZ1—urinary bladder cancer	9.52e-05	0.0012	CbGpPWpGaD
Clarithromycin—CYP1A2—Arachidonic acid metabolism—PTGS2—urinary bladder cancer	9.42e-05	0.00119	CbGpPWpGaD
Clarithromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—urinary bladder cancer	9.34e-05	0.00118	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	9.33e-05	0.00117	CbGpPWpGaD
Clarithromycin—Hypersensitivity—Epirubicin—urinary bladder cancer	9.32e-05	0.000339	CcSEcCtD
Clarithromycin—Urticaria—Doxorubicin—urinary bladder cancer	9.3e-05	0.000338	CcSEcCtD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—urinary bladder cancer	9.28e-05	0.00117	CbGpPWpGaD
Clarithromycin—Abdominal pain—Doxorubicin—urinary bladder cancer	9.25e-05	0.000336	CcSEcCtD
Clarithromycin—Body temperature increased—Doxorubicin—urinary bladder cancer	9.25e-05	0.000336	CcSEcCtD
Clarithromycin—Diarrhoea—Methotrexate—urinary bladder cancer	9.25e-05	0.000336	CcSEcCtD
Clarithromycin—ABCB1—prostate gland—urinary bladder cancer	9.16e-05	0.0303	CbGeAlD
Clarithromycin—Asthenia—Epirubicin—urinary bladder cancer	9.07e-05	0.00033	CcSEcCtD
Clarithromycin—CYP3A7—Metabolism—GSTO2—urinary bladder cancer	9.03e-05	0.00114	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—NAT1—urinary bladder cancer	9.03e-05	0.00114	CbGpPWpGaD
Clarithromycin—Pruritus—Epirubicin—urinary bladder cancer	8.95e-05	0.000325	CcSEcCtD
Clarithromycin—Dizziness—Methotrexate—urinary bladder cancer	8.94e-05	0.000325	CcSEcCtD
Clarithromycin—CYP3A4—renal system—urinary bladder cancer	8.82e-05	0.0292	CbGeAlD
Clarithromycin—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—urinary bladder cancer	8.8e-05	0.00111	CbGpPWpGaD
Clarithromycin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—urinary bladder cancer	8.69e-05	0.00109	CbGpPWpGaD
Clarithromycin—CYP2C19—Biological oxidations—GSTP1—urinary bladder cancer	8.69e-05	0.00109	CbGpPWpGaD
Clarithromycin—Diarrhoea—Epirubicin—urinary bladder cancer	8.65e-05	0.000314	CcSEcCtD
Clarithromycin—Hypersensitivity—Doxorubicin—urinary bladder cancer	8.62e-05	0.000313	CcSEcCtD
Clarithromycin—Vomiting—Methotrexate—urinary bladder cancer	8.59e-05	0.000312	CcSEcCtD
Clarithromycin—CYP2C19—Metapathway biotransformation—GSTP1—urinary bladder cancer	8.57e-05	0.00108	CbGpPWpGaD
Clarithromycin—Rash—Methotrexate—urinary bladder cancer	8.52e-05	0.00031	CcSEcCtD
Clarithromycin—Dermatitis—Methotrexate—urinary bladder cancer	8.51e-05	0.000309	CcSEcCtD
Clarithromycin—CYP3A5—vagina—urinary bladder cancer	8.51e-05	0.0281	CbGeAlD
Clarithromycin—Headache—Methotrexate—urinary bladder cancer	8.47e-05	0.000308	CcSEcCtD
Clarithromycin—Asthenia—Doxorubicin—urinary bladder cancer	8.4e-05	0.000305	CcSEcCtD
Clarithromycin—CYP1A2—Aryl Hydrocarbon Receptor—EP300—urinary bladder cancer	8.38e-05	0.00105	CbGpPWpGaD
Clarithromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—urinary bladder cancer	8.38e-05	0.00105	CbGpPWpGaD
Clarithromycin—Dizziness—Epirubicin—urinary bladder cancer	8.36e-05	0.000304	CcSEcCtD
Clarithromycin—Pruritus—Doxorubicin—urinary bladder cancer	8.28e-05	0.000301	CcSEcCtD
Clarithromycin—CYP3A7—Metabolism—UGT2B7—urinary bladder cancer	8.26e-05	0.00104	CbGpPWpGaD
Clarithromycin—CYP1A2—Aryl Hydrocarbon Receptor—SRC—urinary bladder cancer	8.15e-05	0.00103	CbGpPWpGaD
Clarithromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—urinary bladder cancer	8.15e-05	0.00103	CbGpPWpGaD
Clarithromycin—Vomiting—Epirubicin—urinary bladder cancer	8.04e-05	0.000292	CcSEcCtD
Clarithromycin—Nausea—Methotrexate—urinary bladder cancer	8.03e-05	0.000292	CcSEcCtD
Clarithromycin—Diarrhoea—Doxorubicin—urinary bladder cancer	8.01e-05	0.000291	CcSEcCtD
Clarithromycin—CYP2C19—Biological oxidations—GSTM1—urinary bladder cancer	7.98e-05	0.00101	CbGpPWpGaD
Clarithromycin—Rash—Epirubicin—urinary bladder cancer	7.97e-05	0.00029	CcSEcCtD
Clarithromycin—Dermatitis—Epirubicin—urinary bladder cancer	7.97e-05	0.00029	CcSEcCtD
Clarithromycin—ABCB1—Allograft Rejection—CXCL8—urinary bladder cancer	7.94e-05	0.001	CbGpPWpGaD
Clarithromycin—Headache—Epirubicin—urinary bladder cancer	7.92e-05	0.000288	CcSEcCtD
Clarithromycin—CYP2C19—Metapathway biotransformation—GSTM1—urinary bladder cancer	7.87e-05	0.000992	CbGpPWpGaD
Clarithromycin—ABCB1—HIF-1-alpha transcription factor network—EP300—urinary bladder cancer	7.86e-05	0.00099	CbGpPWpGaD
Clarithromycin—CYP3A4—Biological oxidations—HPGDS—urinary bladder cancer	7.77e-05	0.000979	CbGpPWpGaD
Clarithromycin—ABCB1—seminal vesicle—urinary bladder cancer	7.74e-05	0.0256	CbGeAlD
Clarithromycin—Dizziness—Doxorubicin—urinary bladder cancer	7.74e-05	0.000281	CcSEcCtD
Clarithromycin—ABCB1—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	7.6e-05	0.000957	CbGpPWpGaD
Clarithromycin—ABCB1—Allograft Rejection—IL2—urinary bladder cancer	7.59e-05	0.000955	CbGpPWpGaD
Clarithromycin—CYP3A4—Biological oxidations—GSTT1—urinary bladder cancer	7.54e-05	0.000949	CbGpPWpGaD
Clarithromycin—Nausea—Epirubicin—urinary bladder cancer	7.51e-05	0.000273	CcSEcCtD
Clarithromycin—Vomiting—Doxorubicin—urinary bladder cancer	7.44e-05	0.00027	CcSEcCtD
Clarithromycin—CYP3A7—Metabolism—CYP4B1—urinary bladder cancer	7.43e-05	0.000936	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—urinary bladder cancer	7.38e-05	0.00093	CbGpPWpGaD
Clarithromycin—Rash—Doxorubicin—urinary bladder cancer	7.38e-05	0.000268	CcSEcCtD
Clarithromycin—Dermatitis—Doxorubicin—urinary bladder cancer	7.37e-05	0.000268	CcSEcCtD
Clarithromycin—Headache—Doxorubicin—urinary bladder cancer	7.33e-05	0.000266	CcSEcCtD
Clarithromycin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—urinary bladder cancer	7.3e-05	0.000919	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	7.27e-05	0.000915	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—urinary bladder cancer	7.25e-05	0.000913	CbGpPWpGaD
Clarithromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—urinary bladder cancer	7.14e-05	0.000899	CbGpPWpGaD
Clarithromycin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—urinary bladder cancer	7.14e-05	0.000899	CbGpPWpGaD
Clarithromycin—CYP3A4—female reproductive system—urinary bladder cancer	7.06e-05	0.0234	CbGeAlD
Clarithromycin—CYP3A7—Metabolism—SLC19A1—urinary bladder cancer	7.02e-05	0.000884	CbGpPWpGaD
Clarithromycin—Nausea—Doxorubicin—urinary bladder cancer	6.95e-05	0.000253	CcSEcCtD
Clarithromycin—CYP3A5—Metabolism—GSTZ1—urinary bladder cancer	6.88e-05	0.000867	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—PRSS3—urinary bladder cancer	6.84e-05	0.000862	CbGpPWpGaD
Clarithromycin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—urinary bladder cancer	6.8e-05	0.000856	CbGpPWpGaD
Clarithromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—urinary bladder cancer	6.8e-05	0.000856	CbGpPWpGaD
Clarithromycin—CYP1A2—Biological oxidations—GSTP1—urinary bladder cancer	6.77e-05	0.000852	CbGpPWpGaD
Clarithromycin—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—urinary bladder cancer	6.75e-05	0.000849	CbGpPWpGaD
Clarithromycin—ABCB1—epithelium—urinary bladder cancer	6.73e-05	0.0223	CbGeAlD
Clarithromycin—CYP1A2—Metapathway biotransformation—GSTP1—urinary bladder cancer	6.68e-05	0.000841	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—GSTO2—urinary bladder cancer	6.53e-05	0.000822	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—NAT1—urinary bladder cancer	6.53e-05	0.000822	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—urinary bladder cancer	6.42e-05	0.000809	CbGpPWpGaD
Clarithromycin—ABCB1—renal system—urinary bladder cancer	6.24e-05	0.0206	CbGeAlD
Clarithromycin—CYP1A2—Biological oxidations—GSTM1—urinary bladder cancer	6.22e-05	0.000783	CbGpPWpGaD
Clarithromycin—ABCB1—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	6.2e-05	0.00078	CbGpPWpGaD
Clarithromycin—CYP1A2—Metapathway biotransformation—GSTM1—urinary bladder cancer	6.14e-05	0.000773	CbGpPWpGaD
Clarithromycin—SLC22A7—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	6.13e-05	0.000772	CbGpPWpGaD
Clarithromycin—ABCB1—urethra—urinary bladder cancer	6.13e-05	0.0203	CbGeAlD
Clarithromycin—CYP3A5—Metabolism—UGT2B7—urinary bladder cancer	5.97e-05	0.000752	CbGpPWpGaD
Clarithromycin—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—urinary bladder cancer	5.73e-05	0.000722	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	5.68e-05	0.000715	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	5.65e-05	0.000712	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—urinary bladder cancer	5.63e-05	0.000709	CbGpPWpGaD
Clarithromycin—ABCB1—Allograft Rejection—TNF—urinary bladder cancer	5.53e-05	0.000696	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—TYMP—urinary bladder cancer	5.47e-05	0.000689	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—CYP4B1—urinary bladder cancer	5.37e-05	0.000677	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—GSTZ1—urinary bladder cancer	5.32e-05	0.00067	CbGpPWpGaD
Clarithromycin—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	5.22e-05	0.000658	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—GSTZ1—urinary bladder cancer	5.19e-05	0.000654	CbGpPWpGaD
Clarithromycin—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	5.15e-05	0.000649	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—SLC19A1—urinary bladder cancer	5.08e-05	0.000639	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—GSTO2—urinary bladder cancer	5.05e-05	0.000635	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—NAT1—urinary bladder cancer	5.05e-05	0.000635	CbGpPWpGaD
Clarithromycin—ABCB1—female reproductive system—urinary bladder cancer	5e-05	0.0165	CbGeAlD
Clarithromycin—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	4.96e-05	0.000625	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—NAT2—urinary bladder cancer	4.95e-05	0.000623	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—PRSS3—urinary bladder cancer	4.95e-05	0.000623	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	4.93e-05	0.000621	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—GSTO2—urinary bladder cancer	4.92e-05	0.00062	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—NAT1—urinary bladder cancer	4.92e-05	0.00062	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	4.87e-05	0.000613	CbGpPWpGaD
Clarithromycin—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	4.8e-05	0.000605	CbGpPWpGaD
Clarithromycin—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	4.73e-05	0.000596	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—UGT2B7—urinary bladder cancer	4.61e-05	0.000581	CbGpPWpGaD
Clarithromycin—ABCB1—vagina—urinary bladder cancer	4.52e-05	0.015	CbGeAlD
Clarithromycin—ABCB1—Metabolism—UGT2B7—urinary bladder cancer	4.5e-05	0.000567	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—RRM2—urinary bladder cancer	4.27e-05	0.000538	CbGpPWpGaD
Clarithromycin—ABCB1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	4.19e-05	0.000527	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—CYP4B1—urinary bladder cancer	4.15e-05	0.000523	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—GSTZ1—urinary bladder cancer	4.15e-05	0.000522	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	4.13e-05	0.00052	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—CYP4B1—urinary bladder cancer	4.06e-05	0.000511	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	4.04e-05	0.000509	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—HPGDS—urinary bladder cancer	3.95e-05	0.000498	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—ENO2—urinary bladder cancer	3.95e-05	0.000498	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—TYMP—urinary bladder cancer	3.95e-05	0.000498	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—GSTO2—urinary bladder cancer	3.93e-05	0.000495	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—NAT1—urinary bladder cancer	3.93e-05	0.000495	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—SLC19A1—urinary bladder cancer	3.92e-05	0.000494	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	3.87e-05	0.000487	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—GSTT1—urinary bladder cancer	3.84e-05	0.000483	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—SLC19A1—urinary bladder cancer	3.83e-05	0.000482	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—PRSS3—urinary bladder cancer	3.82e-05	0.000481	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—PRSS3—urinary bladder cancer	3.73e-05	0.00047	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	3.65e-05	0.00046	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—UGT2B7—urinary bladder cancer	3.6e-05	0.000453	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—NAT2—urinary bladder cancer	3.58e-05	0.00045	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	3.53e-05	0.000445	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	3.52e-05	0.000444	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	3.36e-05	0.000423	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	3.27e-05	0.000411	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—CYP4B1—urinary bladder cancer	3.24e-05	0.000408	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	3.2e-05	0.000403	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—NQO1—urinary bladder cancer	3.19e-05	0.000401	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—RRM2—urinary bladder cancer	3.09e-05	0.000389	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	3.07e-05	0.000386	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—SLC19A1—urinary bladder cancer	3.06e-05	0.000385	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—TYMP—urinary bladder cancer	3.06e-05	0.000385	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	3.03e-05	0.000382	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—NAT1—urinary bladder cancer	3.03e-05	0.000382	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—TYMP—urinary bladder cancer	2.98e-05	0.000376	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—PRSS3—urinary bladder cancer	2.98e-05	0.000375	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	2.94e-05	0.00037	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	2.93e-05	0.000369	CbGpPWpGaD
Clarithromycin—ABCB1—lymph node—urinary bladder cancer	2.92e-05	0.00967	CbGeAlD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	2.86e-05	0.000361	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—HPGDS—urinary bladder cancer	2.86e-05	0.00036	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—ENO2—urinary bladder cancer	2.86e-05	0.00036	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	2.77e-05	0.000349	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—GSTT1—urinary bladder cancer	2.77e-05	0.000349	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—NAT2—urinary bladder cancer	2.76e-05	0.000348	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	2.73e-05	0.000343	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	2.71e-05	0.000341	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—NAT2—urinary bladder cancer	2.7e-05	0.00034	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—GSTP1—urinary bladder cancer	2.66e-05	0.000335	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	2.5e-05	0.000315	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—TYMS—urinary bladder cancer	2.47e-05	0.000311	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—GSTM1—urinary bladder cancer	2.44e-05	0.000308	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—NCOR1—urinary bladder cancer	2.44e-05	0.000308	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	2.4e-05	0.000303	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	2.39e-05	0.000301	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—RRM2—urinary bladder cancer	2.39e-05	0.0003	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—TYMP—urinary bladder cancer	2.38e-05	0.0003	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	2.36e-05	0.000297	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—GPX1—urinary bladder cancer	2.34e-05	0.000295	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—RRM2—urinary bladder cancer	2.33e-05	0.000293	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—NQO1—urinary bladder cancer	2.3e-05	0.00029	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	2.3e-05	0.00029	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—ERCC2—urinary bladder cancer	2.3e-05	0.000289	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	2.29e-05	0.000288	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—ENO2—urinary bladder cancer	2.21e-05	0.000278	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—HPGDS—urinary bladder cancer	2.21e-05	0.000278	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.2e-05	0.000277	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—MTHFR—urinary bladder cancer	2.16e-05	0.000272	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—ENO2—urinary bladder cancer	2.16e-05	0.000272	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—HPGDS—urinary bladder cancer	2.16e-05	0.000272	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—NAT2—urinary bladder cancer	2.15e-05	0.000271	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—GSTT1—urinary bladder cancer	2.14e-05	0.00027	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.11e-05	0.000266	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—GSTT1—urinary bladder cancer	2.09e-05	0.000263	CbGpPWpGaD
Clarithromycin—ABCB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	1.96e-05	0.000247	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—GSTP1—urinary bladder cancer	1.92e-05	0.000242	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—RRM2—urinary bladder cancer	1.86e-05	0.000234	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—TYMP—urinary bladder cancer	1.84e-05	0.000231	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—TYMS—urinary bladder cancer	1.79e-05	0.000225	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—NQO1—urinary bladder cancer	1.78e-05	0.000224	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—GSTM1—urinary bladder cancer	1.77e-05	0.000222	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—NCOR1—urinary bladder cancer	1.77e-05	0.000222	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—PPARG—urinary bladder cancer	1.75e-05	0.00022	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—NQO1—urinary bladder cancer	1.74e-05	0.000219	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.73e-05	0.000218	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—ENO2—urinary bladder cancer	1.72e-05	0.000217	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—HPGDS—urinary bladder cancer	1.72e-05	0.000217	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.71e-05	0.000216	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—GPX1—urinary bladder cancer	1.69e-05	0.000213	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—CREBBP—urinary bladder cancer	1.68e-05	0.000212	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—GSTT1—urinary bladder cancer	1.67e-05	0.00021	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—NAT2—urinary bladder cancer	1.66e-05	0.000209	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—ERCC2—urinary bladder cancer	1.66e-05	0.000209	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.64e-05	0.000207	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—MTHFR—urinary bladder cancer	1.56e-05	0.000197	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.51e-05	0.00019	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—GSTP1—urinary bladder cancer	1.49e-05	0.000187	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—GSTP1—urinary bladder cancer	1.45e-05	0.000183	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.44e-05	0.000181	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—RRM2—urinary bladder cancer	1.43e-05	0.000181	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—NQO1—urinary bladder cancer	1.39e-05	0.000175	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—TYMS—urinary bladder cancer	1.38e-05	0.000174	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—PTGS2—urinary bladder cancer	1.38e-05	0.000173	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—GSTM1—urinary bladder cancer	1.37e-05	0.000172	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—NCOR1—urinary bladder cancer	1.37e-05	0.000172	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—TYMS—urinary bladder cancer	1.35e-05	0.00017	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.35e-05	0.00017	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—NCOR1—urinary bladder cancer	1.33e-05	0.000168	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—GSTM1—urinary bladder cancer	1.33e-05	0.000168	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—ENO2—urinary bladder cancer	1.33e-05	0.000167	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	1.33e-05	0.000167	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—GPX1—urinary bladder cancer	1.31e-05	0.000165	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	1.29e-05	0.000162	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—ERCC2—urinary bladder cancer	1.28e-05	0.000162	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—GPX1—urinary bladder cancer	1.28e-05	0.000161	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—PPARG—urinary bladder cancer	1.27e-05	0.000159	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—ERCC2—urinary bladder cancer	1.25e-05	0.000158	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—CREBBP—urinary bladder cancer	1.22e-05	0.000153	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—MTHFR—urinary bladder cancer	1.21e-05	0.000152	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—PTEN—urinary bladder cancer	1.2e-05	0.000151	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—MTHFR—urinary bladder cancer	1.18e-05	0.000148	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.17e-05	0.000148	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—GSTP1—urinary bladder cancer	1.16e-05	0.000146	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—EP300—urinary bladder cancer	1.15e-05	0.000144	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.12e-05	0.000141	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—TYMS—urinary bladder cancer	1.08e-05	0.000136	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—NQO1—urinary bladder cancer	1.07e-05	0.000135	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—NCOR1—urinary bladder cancer	1.06e-05	0.000134	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—GSTM1—urinary bladder cancer	1.06e-05	0.000134	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—GPX1—urinary bladder cancer	1.02e-05	0.000128	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—ERCC2—urinary bladder cancer	1e-05	0.000126	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—PTGS2—urinary bladder cancer	9.96e-06	0.000125	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—PPARG—urinary bladder cancer	9.78e-06	0.000123	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—PPARG—urinary bladder cancer	9.55e-06	0.00012	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—MTHFR—urinary bladder cancer	9.4e-06	0.000118	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—CREBBP—urinary bladder cancer	9.4e-06	0.000118	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—CREBBP—urinary bladder cancer	9.17e-06	0.000116	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	8.93e-06	0.000113	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—PTEN—urinary bladder cancer	8.68e-06	0.000109	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—TYMS—urinary bladder cancer	8.31e-06	0.000105	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—EP300—urinary bladder cancer	8.28e-06	0.000104	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	8.21e-06	0.000103	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	8.21e-06	0.000103	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—GPX1—urinary bladder cancer	7.86e-06	9.9e-05	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	7.72e-06	9.72e-05	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—PTGS2—urinary bladder cancer	7.7e-06	9.69e-05	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—PPARG—urinary bladder cancer	7.62e-06	9.6e-05	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—PTGS2—urinary bladder cancer	7.51e-06	9.46e-05	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—CREBBP—urinary bladder cancer	7.32e-06	9.22e-05	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	7.26e-06	9.14e-05	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—PTEN—urinary bladder cancer	6.71e-06	8.45e-05	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—PTEN—urinary bladder cancer	6.55e-06	8.25e-05	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—EP300—urinary bladder cancer	6.4e-06	8.06e-05	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—EP300—urinary bladder cancer	6.25e-06	7.87e-05	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—PTGS2—urinary bladder cancer	6e-06	7.55e-05	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—PPARG—urinary bladder cancer	5.88e-06	7.41e-05	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	5.65e-06	7.12e-05	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—PTEN—urinary bladder cancer	5.23e-06	6.59e-05	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—EP300—urinary bladder cancer	4.99e-06	6.28e-05	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	4.63e-06	5.83e-05	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—PTEN—urinary bladder cancer	4.04e-06	5.08e-05	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—EP300—urinary bladder cancer	3.85e-06	4.85e-05	CbGpPWpGaD
